Alder BioPharmaceuticals Inc. (Nasdaq: ALDR) named Paul B. Cleveland to the position of interim president and chief executive officer effective immediately to replace Randall C. Schatzmann. The stock price plunged $2.05 to close at $11.55.
Alder BioPharmaceuticals names interim CEO
March 21, 2018 at 17:25 PM EDT
